FIRST-IN-KIND T CELLS CARRYING A CHIMERIC ANTIGEN RECEPTOR AGAINST AN EXTRACELLULAR MATRIX PROTEIN TARGET GLIOBLASTOMA CELLS AND SHOW ANTITUMOR EFFICACY

被引：0
|
作者：
Sengupta, Sadhak [1 ]
Nandhu, Mohan [2 ]
Longo, Sharon [3 ]
Sengupta, Sudarshana [4 ]
Longo, John [2 ]
Sampath, Prakash [4 ]
Viapiano, Mariano [3 ]
机构：
[1] Brown Univ, Warren Alpert Sch Med, Providence, RI 02912 USA
[2] SUNY Upstate Med Univ, Syracuse, NY 13210 USA
[3] SUNY Upstate Med Univ, Dept Neurosurg, Syracuse, NY 13210 USA
[4] Roger Williams Med Ctr, Providence, RI USA
来源：
NEURO-ONCOLOGY | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IMMU-39
引用
收藏
页码：129 / 130
页数：2
相关论文
共 50 条
  • [1] Enhanced the antitumor effects of chimeric antigen receptor T cells in glioblastoma
    Ogunnaike, E. A.
    Valdivia, A.
    Yazdimamaghani, M.
    Leon, E.
    Du, H.
    Khagi, S.
    Gu, Z.
    Savoldo, B.
    Ligler, F. S.
    Hingtgen, S.
    Dotti, G.
    MOLECULAR BIOLOGY OF THE CELL, 2023, 34 (02) : 569 - 569
  • [2] Fibrin gel enhances the antitumor effects of chimeric antigen receptor T cells in glioblastoma
    Ogunnaike, Edikan A.
    Valdivia, Alain
    Yazdimamaghani, Mostafa
    Leon, Ernesto
    Nandi, Seema
    Hudson, Hannah
    Du, Hongwei
    Khagi, Simon
    Gu, Zhen
    Savoldo, Barbara
    Ligler, Frances S.
    Hingtgen, Shawn
    Dotti, Gianpietro
    SCIENCE ADVANCES, 2021, 7 (41)
  • [3] Inhibition of MEK pathway enhances the antitumor efficacy of chimeric antigen receptor T cells against neuroblastoma
    Tomida, Akimasa
    Yagyu, Shigeki
    Nakamura, Kayoko
    Kubo, Hiroshi
    Yamashima, Kumiko
    Nakazawa, Yozo
    Hosoi, Hajime
    Iehara, Tomoko
    CANCER SCIENCE, 2021, 112 (10) : 4026 - 4036
  • [4] Antitumor efficacy of chimeric antigen receptor T cells against EGFRvIII-expressing glioblastoma in C57BL/6 mice
    Chen, Muhua
    Sun, Ruixin
    Shi, Bizhi
    Wang, Yi
    Di, Shengmeng
    Luo, Hong
    Sun, Yansha
    Li, Zonghai
    Zhou, Min
    Jiang, Hua
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 113
  • [5] Commentary: Chimeric Antigen Receptor T-Cell Therapy: Updates in Glioblastoma Treatment GLIOBLASTOMA: A CASE FOR CHIMERIC ANTIGEN RECEPTOR T CELLS
    Yu, Xiaoling
    Curry, William T.
    Gerstner, Elizabeth R.
    Cahill, Daniel P.
    Nahed, Brian V.
    Maus, Marcela V.
    Carter, Bob S.
    Choi, Bryan D.
    NEUROSURGERY, 2021, 89 (01) : E68 - E69
  • [6] The update of chimeric antigen receptor-T cells therapy in glioblastoma
    Chou, Chi-Jen
    Lin, Chun-Fu
    Chen, Yi-Wei
    Huang, Pin-, I
    Yang, Yi-Ping
    Wang, Mong-Lien
    Hung, Kai-Feng
    Lee, Yi-Yen
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2020, 83 (05) : 442 - 445
  • [7] Use of Chimeric Antigen Receptor T Cells as a Potential Therapeutic for Glioblastoma
    Khan, Muhammad Babar
    Chakraborty, Shamik
    Boockvar, John Andrew
    NEUROSURGERY, 2017, 80 (05) : N33 - N34
  • [8] Allogeneic EGFRvIII chimeric antigen receptor T cells for treatment of glioblastoma
    Wong, Oi Kwan
    Dusseaux, Mathilde
    Ma, Jing-Tyan
    Au, Melinda
    Leduc, Sophie
    Chou, Joyce
    Yu, Jessica M.
    Bateman, Marjorie
    Pertel, Thomas
    Lindquist, Kevin C.
    Smith, Julianne
    Sasu, Barbra
    Liu, Shu-Hui
    CANCER RESEARCH, 2017, 77
  • [9] PSCA is a target of chimeric antigen receptor T cells in gastric cancer
    Wu, Di
    Lv, Jiang
    Zhao, Ruocong
    Wu, Zhiping
    Zheng, Diwei
    Shi, Jingxuan
    Lin, Simiao
    Wang, Suna
    Wu, Qiting
    Long, Youguo
    Li, Peng
    Yao, Yao
    BIOMARKER RESEARCH, 2020, 8 (01)
  • [10] PSCA is a target of chimeric antigen receptor T cells in gastric cancer
    Di Wu
    Jiang Lv
    Ruocong Zhao
    Zhiping Wu
    Diwei Zheng
    Jingxuan Shi
    Simiao Lin
    Suna Wang
    Qiting Wu
    Youguo Long
    Peng Li
    Yao Yao
    Biomarker Research, 8
12345